Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CEMTREX INC (CETX)
|
Add to portfolio |
|
|
|
| Price: |
$0.96
| | Metrics |
| OS: |
998.3
|
k
| |
|
|
| Market cap: |
$957.4
|
k
| |
|
|
|
Net debt:
|
$15.1
|
M
| |
|
|
|
EV:
|
$16
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| Revenues | 50.3 | 43.1 | 43.5 | 39.3 | 22.6 | 120.6 | 93.7 | 56.9 |
| Revenue growth | 16.6% | -0.9% | 10.8% | 73.4% | -81.2% | 28.7% | 64.7% | 19.4% |
| Cost of goods sold | 31.2 | 26.2 | 25.9 | 23.7 | 14.4 | 80.7 | 64.5 | 40.6 |
| Gross profit | 19.1 | 17.0 | 17.6 | 15.6 | 8.2 | 39.9 | 29.2 | 16.3 |
| Gross margin | 37.9% | 39.3% | 40.5% | 39.6% | 36.3% | 33.1% | 31.2% | 28.7% |
| Research and development | 4.9 | 3.2 | 1.8 | 1.5 | 5.6 | | | |
| General and administrative | 27.8 | 22.5 | 20.4 | 21.5 | 15.2 | 34.8 | 24.1 | 13.8 |
| EBIT | -13.6 | -8.7 | -4.6 | -7.8 | -13.8 | 5.1 | 5.1 | 2.5 |
| EBIT margin | -27.0% | -20.3% | -10.5% | -19.8% | -60.8% | 4.2% | 5.4% | 4.4% |
| Pre-tax income | -13.5 | 0.8 | -7.4 | -12.6 | -13.9 | 4.5 | 6.1 | 2.8 |
| Income taxes | -0.2 | 0.4 | 2.1 | 1.3 | 2.9 | 0.1 | 1.1 | 0.0 |
| Tax rate | 1.5% | 48.8% | | | | 2.6% | 17.9% | 0.0% |
| Earnings from continuing ops | -13.0 | 0.5 | -9.7 | -13.8 | -11.9 | 3.2 | 5.0 | 2.8 |
| Earnings from discontinued ops | | -8.3 | -0.8 | -10.6 | 1.8 | | | |
| Net income | -13.0 | -7.8 | -10.5 | -24.3 | -10.2 | 3.2 | 5.0 | 2.8 |
| Net margin | -25.9% | -18.1% | -24.1% | -62.0% | -44.9% | 2.6% | 5.3% | 5.0% |
| |
| Diluted EPS | ($0.52) | $0.02 | ($1.00) | ($6.07) | ($8.50) | $0.31 | $0.59 | $0.41 |
| Shares outstanding (diluted) | 24.8 | 18.9 | 9.6 | 2.3 | 1.4 | 10.2 | 8.6 | 6.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|